Prosecution Insights
Last updated: May 29, 2026

UNIVERSITY OF UTAH RESEARCH FOUNDATION

35 pending office actions • 30 art units • 34 examiners • 0 of 35 (0%) have an AI response strategy ready • 43 patents granted in the last 365 days

Portfolio Summary

35
Total Pending OAs
26
Non-Final OAs
9
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 35 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

25
Overdue
1
Due this week
3
Due this month
5
Due in next 60 days
1
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 35 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (25)Due ≤ 7 days (1)Due ≤ 30 days (3)Due ≤ 60 days (5)Due later (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

2
Hard (6%)
27
Medium (77%)
2
Easy (6%)
4
Unknown (11%)

Rejection Statute Mix

BucketCases
§101 only2 (6%)
§103 only25 (71%)
§102 only2 (6%)
§112 only2 (6%)
No statute on record4 (11%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

19
Life Sciences
54% of docket
1
Information Tech
3% of docket
1
Communications
3% of docket
2
Semiconductors
6% of docket
12
Mechanical / Eng
34% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

350 h
Manual time on pending OAs
70 h
Time saved (low, 20%)
122 h
Time saved (mid, 35%)
3.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
ESPINOSA, CLAUDIA EDILMA 2 53.2% +58.5%
YANG, ANDREW 1 84.1% +10.5%
MATTHEWS, MADISON ROSE 1 79.6% +35.3%
JASANI, ASHISH SHIRISH 1 67.3% +25.9%
KU, SI MING 1 72.4% +33.2%
LE, HUNG D 1 90.2% +6.1%
BOLES, SAMEH RAAFAT 1 70.0% +24.7%
BATES, DAVID W 1 76.2% +17.0%
WOZNIAK, JAMES S 1 59.6% +39.4%
HORLICK, KENNETH R 1 78.9% +15.2%

Quick Wins (2)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18949394 SYSTEMS AND METHODS FOR FACILITATING RAPID GENOME SEQUENCE ANALYSIS LE, HUNG D 163d overdue
18875819 CARTILAGE AND BONE HARVEST AND DELIVERY SYSTEM AND METHODS YANG, ANDREW 2d overdue

Hard Cases (2)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
17625866 CLOSTRIDIA CONSORTIA COMPOSITIONS AND METHODS OF TREATING OBESITY, METABOLIC SYNDROME AND IRRITABLE BOWEL DISEASE ESPINOSA, CLAUDIA EDILMA 60d overdue
18075680 REAL-TIME COORDINATED OPERATION OF POWER AND ELECTRIC RIDE SYSTEMS HENZE, DAVID V 13d

Interview Candidates (10)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18638155 PSEUDOTELEPATHY HEADSET WOZNIAK, JAMES S 105d overdue
17625866 CLOSTRIDIA CONSORTIA COMPOSITIONS AND METHODS OF TREATING OBESITY, METABOLIC SYNDROME AND IRRITABLE BOWEL DISEASE ESPINOSA, CLAUDIA EDILMA 60d overdue
18950105 HYDRAULIC GROWING ROD KU, SI MING 58d overdue
18968893 TRAUMA GURNEY WITH ENHANCED PATIENT TRANSFER CAPABILITIES MATTHEWS, MADISON ROSE 18d overdue
18494072 METHODS FOR FAST NUCLEIC ACID AMPLIFICATION HORLICK, KENNETH R 17d overdue
17594643 METABOLIC ENGINEERING OF NON-PATHOGENIC ESCHERICHIA COLI STRAINS FOR THE CONTROLLED PRODUCTION OF LOW MOLECULAR WEIGHT HEPAROSAN AND SIZE-SPECIFIC HEPAROSAN OLIGOSACCHARIDES ESPINOSA, CLAUDIA EDILMA 4d overdue
18875819 CARTILAGE AND BONE HARVEST AND DELIVERY SYSTEM AND METHODS YANG, ANDREW 2d overdue
18869772 SYSTEM AND METHOD FOR SHARPENING THE FOCAL VOLUME OF THERAPEUTIC AND IMAGING SYSTEMS JASANI, ASHISH SHIRISH 34d

Top Art Units

Art UnitApps
3775 3
1675 2
3783 2
1654 2
3673 1
3798 1
2161 1
3799 1
2655 1
1681 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18875819 CARTILAGE AND BONE HARVEST AND DELIVERY SYSTEM AND METHODS YANG, ANDREW 3775 §103 Non-Final OA 2d overdue Pending Dec 17, 2024
18968893 TRAUMA GURNEY WITH ENHANCED PATIENT TRANSFER CAPABILITIES MATTHEWS, MADISON ROSE 3673 §103 Non-Final OA 18d overdue Pending Dec 04, 2024
18869772 SYSTEM AND METHOD FOR SHARPENING THE FOCAL VOLUME OF THERAPEUTIC AND IMAGING SYSTEMS JASANI, ASHISH SHIRISH 3798 §103 Non-Final OA 34d Pending Nov 26, 2024
18950105 HYDRAULIC GROWING ROD KU, SI MING 3775 Other Non-Final OA 58d overdue Pending Nov 17, 2024
18949394 SYSTEMS AND METHODS FOR FACILITATING RAPID GENOME SEQUENCE ANALYSIS LE, HUNG D 2161 §112 Non-Final OA 163d overdue Pending Nov 15, 2024
18739098 UNICORTICAL BONE FIXATION AND SURGICAL METHODS BOLES, SAMEH RAAFAT 3775 §103 Non-Final OA 57d Pending Jun 10, 2024
18707298 ROTATIONAL GUIDED GROWTH DEVICES, SYSTEMS, AND METHODS BATES, DAVID W 3799 §103 Final Rejection 61d Pending May 03, 2024
18638155 PSEUDOTELEPATHY HEADSET WOZNIAK, JAMES S 2655 §103 Non-Final OA 105d overdue Pending Apr 17, 2024
18494072 METHODS FOR FAST NUCLEIC ACID AMPLIFICATION HORLICK, KENNETH R 1681 §103 Non-Final OA 17d overdue Pending Oct 25, 2023
18475627 SCHEDULING FOR HEAVY EQUIPMENT USING SENSOR DATA ABOUZAHRA, REHAM K 3625 §103 Non-Final OA 49d overdue Pending Sep 27, 2023
18546258 TREATMENT OF MYOPIA HUANG, GIGI GEORGIANA 1613 Other Final Rejection 21d Pending Aug 11, 2023
18447171 THIN FLUID LAYERS AND STREAMS FACILITATED, FORCE-BASED ATOM, ION, MOLECULE, AND FINE PARTICLE SEPARATORS AND METHODS OF USING THE SAME MORALES, RICARDO D 1738 §103 Non-Final OA 54d Pending Aug 09, 2023
18257083 ELECTROMAGNETIC MOTOR FOR OPERATION IN A HIGH MAGNETIC FIELD ENVIRONMENT SUBRAMANIAN, VISWANATHAN 2834 §103 Final Rejection 66d overdue Pending Jun 12, 2023
18202764 LUNG-ON-CHIP DEVICE WITH INTEGRATED EXTRACELLULAR MATRIX MEMBRANE YOH, JULIUS FRANCIS 1799 §103 Non-Final OA 18d overdue Pending May 26, 2023
18323996 SELECTIVE APPROACH TO SEPARATE AND CONCENTRATE RARE EARTH ELEMENTS DRODGE, JOSEPH W 1773 §103 Non-Final OA 2d overdue Pending May 25, 2023
18117316 ELECTRIC GRIP GAUGE FOR ASSESSING HAND DEXTERITY EISEMAN, ADAM JARED 3791 §103 Final Rejection 8d overdue Pending Mar 03, 2023
18173680 Compositions and Methods for Killing PD-1 Positive Cells BERHANE, SELAM 1675 §102 Non-Final OA 40d Pending Feb 23, 2023
18022411 OCCLUSION BALLOONS AND DISTAL THROMBECTOMY CATHETERS WITH BLOOD FLOW SENSORS AND AUTOMATED INFLATION HALL, DEANNA K 3783 §103 Non-Final OA 150d overdue Pending Feb 21, 2023
18098538 THERAPEUTIC DELIVERY DEVICE VU, QUYNH-NHU HOANG 3783 §103 Non-Final OA 33d Pending Jan 18, 2023
18075680 REAL-TIME COORDINATED OPERATION OF POWER AND ELECTRIC RIDE SYSTEMS HENZE, DAVID V 2859 §101 Final Rejection 13d Pending Dec 06, 2022
17920695 Implantable Transition Micro-Electrodes MINCHELLA, ADAM ZACHARY 3794 §103 Non-Final OA 45d overdue Pending Oct 21, 2022
17929062 ASSESSMENT OF MELANOMA THERAPY RESPONSE GRAY, JESSICA 1682 §103 Final Rejection 44d overdue Pending Sep 01, 2022
17900240 IMPLANTABLE BONE SCAFFOLDS INCLUDING AT LEAST ONE INTEGRATION AID, METHODS OF MAKING AND USING THE SAME LIU, TRACY 1614 Other Final Rejection 35d overdue Pending Aug 31, 2022
17801002 METHODS FOR REHABILITATING HEART FAILURE USING GENE THERAPY AFREMOVA, VERA 1653 §103 Non-Final OA 7d Pending Aug 19, 2022
17796494 HIGH MOLECULAR WEIGHT HEPARIN COMPOSITIONS AND METHODS FOR DIAGNOSING, TREATING AND MONITORING EOSINOPHIL MEDIATED INFLAMMATORY DISEASES MEJIAS, SAMANTHA LEE 1618 §103 Non-Final OA 2d overdue Pending Jul 29, 2022
17776563 OPTIDICER CONSTRUCT FOR AGE-RELATED MACULAR DEGENERATION MONTANARI, DAVID A 1632 §102 Non-Final OA 66d overdue Pending May 12, 2022
17688699 DEVICES, SYSTEMS AND METHODS FOR PREDICTING FUTURE PHARMACOKINETIC PARAMETERS FOR A PATIENT UTILIZING INPUTS OBTAINED FROM AN ELECTROCHEMICAL SENSOR WHALEY, PABLO S 3619 §103 Non-Final OA 36d overdue Pending Mar 07, 2022
17640627 COMPOSITIONS AND METHODS FOR USING SILK-ELASTINLIKE PROTEIN-BASED POLYMERS FONTAINHAS, AURORA M 1675 §103 Non-Final OA 113d overdue Pending Mar 04, 2022
17625866 CLOSTRIDIA CONSORTIA COMPOSITIONS AND METHODS OF TREATING OBESITY, METABOLIC SYNDROME AND IRRITABLE BOWEL DISEASE ESPINOSA, CLAUDIA EDILMA 1654 §101 Non-Final OA 60d overdue Pending Jan 10, 2022
17616111 NOVEL LIVE-CELL ASSAY FOR NEURONAL ACTIVITY NICOL, ALEXANDER W 1634 §103 Non-Final OA 2d overdue Pending Dec 02, 2021
17594643 METABOLIC ENGINEERING OF NON-PATHOGENIC ESCHERICHIA COLI STRAINS FOR THE CONTROLLED PRODUCTION OF LOW MOLECULAR WEIGHT HEPAROSAN AND SIZE-SPECIFIC HEPAROSAN OLIGOSACCHARIDES ESPINOSA, CLAUDIA EDILMA 1654 §103 Final Rejection 4d overdue Pending Oct 25, 2021
17422646 USE OF MESENCHYMAL STEM CELL SHEETS FOR PREVENTING UTERINE SCAR FORMATION LEVIN, JOEL D 1633 §103 Non-Final OA 81d overdue Pending Jul 13, 2021
17420589 FLUORAPATITE-CONTAINING STRUCTURES STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH PALENIK, JEFFREY T 1615 Other Final Rejection 22d overdue Pending Jul 02, 2021
16745181 PRODUCTION OF CARBON PRODUCTS IN MOLTEN SALT MEDIA JEBUTU, MOFOLUWASO SIMILOLUWA 1795 §103 Non-Final OA 26d Pending Jan 16, 2020
16610408 COMPOSITIONS AND METHODS OF USE OF ARC CAPSIDS SHIN, DANA H 1635 §112 Non-Final OA 58d overdue Pending Nov 01, 2019

Managing UNIVERSITY OF UTAH RESEARCH FOUNDATION's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month